Telomerase contributes to tumorigenesis by a telomere length-independent mechanism
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Once immortalized, human cells are susceptible to transformation by introduction of an oncogene such as ras . Several lines of evidence now suggest that the maintenance of telomere length is a major determinant of replicative lifespan in human cells and thus of the immortalized state. The majority of human tumor cells acquire immortality through expression of the catalytic subunit of telomerase (hTERT), whereas others activate an alternative mechanism of telomere maintenance (ALT) that does not depend on the actions of telomerase. We have examined whether ALT could substitute for telomerase in the processes of transformation in vitro and tumorigenesis in vivo . Expression of oncogenic H-Ras in the immortal ALT cell line GM847 did not result in their transformation. However, subsequent ectopic expression of hTERT in these cells imparted a tumorigenic phenotype. Indeed, this outcome was also observed after introduction of a mutant hTERT that retained catalytic activity but was incapable of maintaining telomere length. These studies indicate that hTERT confers an additional function that is required for tumorigenesis but does not depend on its ability to maintain telomeres.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Overexpression experiments in transgenic mice and in human cells have shown that TERT exhibits activities in cellular transformation (136-138), proliferation (139), stem cell biology (140-142), cell survival (143,144) and chromatin regulation (145).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [136]
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, recent findings indicate that TERT promotes tumor development even in settings of ample telomere reserve, although the mechanisms underlying these telomere length-independent activities of TERT remain unclear9–13.”
From Conditional telomerase induction causes proliferation of hair follicle stem cells (2005) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: Autoimmunity as a Consequence of Retrovirus-Mediated Expression of C-FLIP in Lymphocytes
Parijs, L. V., Refaeli, Y., Abbas, A. K., & Baltimore, D. (1999) · Immunity · doi:10.1016/s1074-7613(00)80150-8 · Cited by 149
RetractedAutoimmunity as a Consequence of Retrovirus-Mediated Expression of C-FLIP in Lymphocytes
Parijs, L. V., Refaeli, Y., Abbas, A. K., & Baltimore, D. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.003 · Cited by 31
RetractedThe serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Mammalian Telomeres End in a Large Duplex Loop
Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & de Lange, T. (1999) · Cell · doi:10.1016/s0092-8674(00)80760-6 · Cited by 2,447
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Self-citationTelomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Research works printed but not linked: 4
- Rich J N, Guo C, McLendon R E, Bigner D D, Wang X F, Counter C M. Cancer Res. 2001;61:3556–3560. [PubMed] [Google Scholar]
- Kuperwasser C, Pinkas J, Hurlbut G D, Naber S P, Jerry D J. Cancer Res. 2000;60:2723–2729. [PubMed] [Google Scholar]
- Zimonjic D, Brooks M W, Popescu N, Weinberg R A, Hahn W C. Cancer Res. 2001;61:8838–8844. [PubMed] [Google Scholar]
- Yeager T R, Neumann A A, Englezou A, Huschtscha L I, Noble J R, Reddel R R. Cancer Res. 1999;59:4175–4179. [PubMed] [Google Scholar]
Cited by
Items 301–400 of 434
Global expression profile of telomerase-associated genes in HeLa cells
Varshney, A., Ramakrishnan, S. K., Sharma, A., Santosh, B., Bala, J., Yadava, P. K., & Jaiswal, R. K. (2014) · Gene · doi:10.1016/j.gene.2014.06.018 · Cited by 12
“Expression of oncogenic H-Ras in ALT cells was insufficient to confer tumorigenicity, where as subsequent ectopic overexpression of hTERT or a catalytically active mutant form of hTERT that has lost the ability to elongate telomeres results in transformation (Stewart et al., 2002).”
BackgroundTélomère et cancer : quoi de plus à la fin ?
Brunori, M., & Gilson, É. (2005) · médecine/sciences · doi:10.1051/medsci/200521137 · Cited by 18
“Jusqu’à présent, il semblait clair que c’était la fonction catalytique de l’enzyme qui devait être ciblée; cependant, certains travaux suggèrent que la télomérase joue d’autres rôles que de maintenir une taille correcte d’ADN télomérique, et que ces activités non conventionnelles sont importantes pour la transformatio…”
BackgroundUsing DNA Damage Responses to Prevent and Treat Skin Cancers
Gilchrest, B. A. (2004) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2004.tb00619.x · Cited by 12
Non-Canonical TERT Activity Initiates Osteogenesis in Calcific Aortic Valve Disease
Cuevas, R. A., Hortells, L., Chu, C. C., Wong, R., Crane, A., Boufford, C. K., Regan, C., Moorhead, W. J., Bashline, M. J., Parwal, A., et al. (2025) · Circulation Research · doi:10.1161/circresaha.122.321889 · Cited by 11
“15,16,69 In a wire-injury restenosis model, TERT binds to the transcription factors SP1 (specificity protein 1) at the VEGF promoter and E2F1 at MCM7 , CCNA1 , and PCNA promoters, stimulating SMC proliferation and neointima formation.”
Telomerase-Mediated Apoptosis of Chicken Lymphoblastoid Tumor Cell Line by Lanthanum Chloride
Zhang, Z., Wang, J., Li, J., & Xu, S. (2011) · Biological Trace Element Research · doi:10.1007/s12011-011-9027-8 · Cited by 11
“Stewart’s [38] study indicated that hTERT conferred an additional function that is required for tumorigenesis.”
BackgroundTelomeres shorten and then lengthen before fledging in Magellanic penguins (Spheniscus magellanicus)
Cerchiara, J. A., Risques, R. A., Prunkard, D. E., Smith, J. R., Kane, O. J., & Boersma, P. D. (2017) · Aging · doi:10.18632/aging.101172 · Cited by 12
“There is some evidence, however, that telomerase may remain active in some adult long-lived birds (Sterna hirundo; Oceanodroma leucorhoa) compared to short lived ones [45], which could explain the telomere elongation we observed as it is the only known reverse-transcriptase to elongate telomeres [30, 32, 47-53].”
BackgroundNo attenuation of the ATM-dependent DNA damage response in murine telomerase-deficient cells
Erdmann, N., & Harrington, L. A. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.11.009 · Cited by 11
Xing, J., Zhu, Y. L., Zhao, H., Yang, H., Chen, M., Spitz, M. R., & Wu, X. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0615 · Cited by 11
“A previous study found that telomerase could facilitate the telomere length-independent tumorigenicity of Ras-transformed, immortalized GM847 cells using an in vitro tumorigenesis assay (19).”
MethodCluster analysis of the p53 genetic regulatory network: topology and biology
Hallinan, J. S. (2005) · IEEE International Geoscience and Remote Sensing Symposium (IGARSS) · doi:10.1109/cibcb.2004.1393924 · Cited by 11
“The downstream nodes in this cluster are all transcription factors, apart from the cell growth regulator CDKN2B and the gene for telomerase reverse transcriptase (TERT), deregulation of which is hypothesized to be involved in oncogenesis [22].”
BackgroundTelomeres and telomerase: From basic research to clinical applications
Ségal-Bendirdjian, E., & Gilson, É. (2007) · Biochimie · doi:10.1016/j.biochi.2007.10.003 · Cited by 11
(2022) · doi:10.1101/2022.08.23.504425 · Cited by 11
Maintenance of R-loop structures by phosphorylated hTERT preserves genome integrity
Machitani, M., Nomura, A., Yamashita, T., Yasukawa, M., Ueki, S., Fujita, K.-I., Ueno, T., Yamashita, A., Tanzawa, Y., Watanabe, M., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01427-6 · Cited by 10
“Consistent with several studies 23–25 , we ascertained that ALT cells exhibited no telomerase activity (Fig.”
Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation
Lin, S., Wei, J., Wunderlich, M., Chou, F., & Mulloy, J. C. (2016) · Oncotarget · doi:10.18632/oncotarget.11093 · Cited by 11
“In addition, hTERT can enhance stem cell activity and facilitate oncogeneinduced transformation via functions beyond telomere maintenance, including promoting cell proliferation, reducing DNA damage and increasing cell survival [20, 21].”
BackgroundResultHe, X., Qiao, Q., Ge, N., Jing, N., Shen, S., Wang, Z., Yang, Y., & Bao, G. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-312 · Cited by 11
“For example, Stewart et al. [ 28 ] reported that the telomerase could facilitate the tumorigenicity of ras-transformed, already-immortalized GM847 cells.”
BackgroundZanjani, L. S., Madjd, Z., Rasti, A., Asgari, M., Abolhasani, M., Tam, K. J., Roudi, R., Mælandsmo, G. M., Fodstad, Ø., & Andersson, Y. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01302 · Cited by 10
“Several studies have shown that malignant cells from different types of cancer have telomerase expression levels that correlate with tumor-initiating ability (18, 19).”
BackgroundTelomerase Activity and Genetic Alterations in Primary Breast Carcinomas
Papadopoulou, A., Trangas, T. T., Teixeira, M. R., Heim, S., Dimitriadis, E., Tsarouha, H., Andersen, J. A., Evangelo, E., Ioannidis, P., Agnantis, N. J., et al. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80009-x · Cited by 11
“The most convincing evidence for an alternative role for telomerase derives from the fact that the ectopic expression of mutant hTERT, which retains its catalytic activity but could not maintain telomere length, contributes to tumorigenesis in collaboration with activated H-Ras in ALT immortal cell lines [8].”
BackgroundTelomere length in normal and neoplastic canine tissues
Cadile, C. D., Kitchell, B. E., Newman, R. G., Biller, B. J., & Hetler, E. R. (2007) · American Journal of Veterinary Research · doi:10.2460/ajvr.68.12.1386 · Cited by 12
Marie-Egyptienne, D. T., Brault, M. E., Zhu, S., & Autexier, C. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.10.020 · Cited by 11
Aono, J., Ruiz‐Rodriguez, E., 青华, Findeisen, H. M., Jones, K. L., Heywood, E. B., & Bruemmer, D. (2016) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2016.01.002 · Cited by 10
“Although this mitogenic activity of telomerase was long thought to result from its ability to maintain telomeres, recent evidence indicates that TERT enhances proliferation through mechanisms independent of telomere elongation (20,21).”
BackgroundWu, Y., Cai, Z., Cross, D., Noble, J. R., Prest, K., Littleboy, J. B., Cohen, S. B., Edlundh, B., Koh, J. M. S., Xu, R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67190-w · Cited by 9
“These fi ndings are consistent with the hypothesis that a cancer cell that initially becomes immortalized through ALT activation may acquire an additional survival or growth advantage through subsequent activation of TEL 48,49 .”
Xu, W., Wang, Y., Tong, H., Qian, W., & Jin, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113199 · Cited by 9
“[25] found that telomerase contributes to tumorigenesis by a mechanism that is independent of telomere length.”
BackgroundHelicobacter pylori Induces a Novel NF-kB/LIN28A/let-7a/hTERT Axis to Promote Gastric Carcinogenesis
Li, S., Zeng, J., Ma, L., Li, S., Chen, C., Jia, J., & Liang, X. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0678 · Cited by 10
“Although reactivated telomerase in cancer mainly serves to elongate telomere length, mounting evidence suggests that telomereindependent roles of TERT are vital as well for oncogenesis (14, 15).”
BackgroundPotential role of melatonin in prevention and treatment of lung cancer
Ngai, Z. N., Chok, K. C., Ng, K. Y., Koh, R. Y., & Chye, S. M. (2022) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2022-0018 · Cited by 12
Télomères : un Nobel pour le début de la fin
Rajpar, S., Guittat, L., & Mergny, J. (2011) · Bulletin du Cancer · doi:10.1684/bdc.2011.1378 · Cited by 9
Molecular and cellular dynamics of squamous cell carcinomas across tissues
Kudelka, M. R., Lavin, Y., Sun, S., & Fuchs, E. V. (2024) · Genes & Development · doi:10.1101/gad.351990.124 · Cited by 10
Association between hTERT rs2736100 polymorphism and sensitivity to anti-cancer agents
Kim, J. J., Jones‐Hall, Y., Wei, R., Myers, J. L., Qi, Y., Knipp, G. T., & Liu, W. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00162 · Cited by 8
“…that telomerase may have the capacity to directly regulate cancer-promoting pathways through several mechanisms, including telomere elongation-independent activity (Stewart et al., 2002; Blasco and Hahn, 2003; Smith et al., 2003; Cong and Shay, 2008; Parkinson et al., 2008; Mukherjee et al., 2011).”
BackgroundRamakrishnan, S. K., Varshney, A., Sharma, A., Das, B. C., & Yadava, P. K. (2014) · Tumor Biology · doi:10.1007/s13277-014-1729-z · Cited by 8
“Therefore, constituents of telomerase have been projected to have additional role besides telomere maintenance by having direct or indirect cross-talks with other cellular gene products [4, 5, 7, 11, 13].”
BackgroundTranscriptional regulation of the human telomerase reverse transcriptase: New insights
Chebel, A., & Ffrench, M. (2010) · Transcription · doi:10.4161/trns.1.1.12062 · Cited by 9
Passanisi, V. J., & Spencer, S. L. (2026) · iScience · doi:10.1016/j.isci.2026.114801 · Cited by 7
Treatment of Viral and Neoplastic Diseases with Double-Stranded RNA Derivatives and Other New Agents
Ambrus, J. L., Chadha, K. C., Islam, A., Akhter, S., & Ambrus, J. L. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100801 · Cited by 7
Qi, D.-L., Ohira, T., Oshimura, M., & Kugoh, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.003 · Cited by 7
Inhibition of gene amplification in telomerase deficient immortalized mouse embryonic fibroblasts
Rebuzzini, P., Martinelli, P., Blasco, M. A., Giulotto, E., & Mondello, C. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl158 · Cited by 8
Choi, J., Southworth, L. K., Sarin, K. Y., Venteicher, A. S., Ma, W., Chang, W., Cheung, P., Jun, S., Artandi, M. K., Shah, N., et al. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0040010.eor · Cited by 7
Fetal human neural progenitors can be the target for tumor transformation
Wang, Y., Bai, Y., Li, X., Hu, Q., Lin, C., Xiao, Z., Liu, Y., Xu, J., Li, S., & Li, L. (2004) · Neuroreport · doi:10.1097/00001756-200408260-00015 · Cited by 7
“It was reported that ectopic expression of hTERT can confer an additional function required for tumorigenesis [18,19], although there are some evidences that hTERT can immortalize hNPCs with normal karyotype and phenotype [20,21]; the third is use of selective drugs and cell amplification.”
BackgroundPierpoint, M., Floyd, W., Wisdom, A. J., Luo, L., Ma, Y., Dickson, B. C., Waitkus, M. S., & Kirsch, D. G. (2025) · iScience · doi:10.1016/j.isci.2025.112357 · Cited by 6
RETRACTED: Tumorigenic study on hepatocytes coexpressing SV40 with Ras
Sun, B., Chen, M., Hawks, C. L., Hornsby, P. J., & Wang, X. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20137 · Cited by 6
“telomere length independent mechanism [28].”
RetractedNeoplastic conversion of human colon smooth muscle cells: No requirement for telomerase
Liang, S., Kahlenberg, M. S., Rousseau, D. L., & Hornsby, P. J. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20405 · Cited by 6
Well-Known Signaling Proteins Exert New Functions in the Nucleus and Mitochondria
Büchner, N., Altschmied, J., Jakob, S., Saretzki, G. C., & Haendeler, J. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2994 · Cited by 8
“Stewart et al. demonstrated that TERT enhances tumorigenesis independent of its telomeric function although the mechanism for this effect is not entirely clear (37).”
Telomerase flies the coop: the telomerase RNA component as a viral-encoded oncogene
Artandi, S. E. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060849 · Cited by 7
“In human cells that maintain their telomeres through a telomerase-independent mechanism (known as alternative lengthening of telomeres [ALT]), expression of TERT was necessary for malignant transformation and growth of tumors in immunocompromised mice (16).”
BackgroundNishio, S., Ohira, T., Sunamura, N., Oshimura, M., Ryoke, K., & Kugoh, H. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.09.119 · Cited by 7
Length Does Not Matter: A New Take on Telomerase Reverse Transcriptase
Goodman, W. A., & Jain, M. K. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.220343 · Cited by 6
Targeting Telomerase in Hematologic Malignancy
Maritz, M. F., Napier, C. E., Wen, V. W., & MacKenzie, K. L. (2010) · Future Oncology · doi:10.2217/fon.10.42 · Cited by 5
“Accumulating evidence suggests that telomerase has other properties, in addition to its well-known telomere maintenance function, that contribute to tumorigenesis [38].”
BackgroundResultCao, X., Kong, C. M., Mathi, K. M., Lim, Y. P., Cacheux-Rataboul, V., & Wang, X. (2014) · BMC Biochemistry · doi:10.1186/1471-2091-15-17 · Cited by 5
“In addition, human cells utilize alternative lengthening of telomeres pathway for telomere maintenance can only be transformed when co-expressing hTERT and oncogenic-Ras, indicating that hTERT is indispensable for cancer transformation [11,12].”
BackgroundPark, Y. P., Choi, S., Cho, M. Y., Song, E. Y., Kim, J. W., Paik, S., Kim, Y. K., Kim, J. W., & Lee, H. G. (2006) · Annals of Laboratory Medicine · doi:10.3343/kjlm.2006.26.4.287 · Cited by 6
“Recent findings have revealed that telomerase confers an additional function required for tumorigenesis, which is independent of its ability to maintain the telomere[3].”
BackgroundAref, S., Saeed, A. A., Menshawy, N. E., Abdalla, D., & Ashery, M. E. (2019) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23133 · Cited by 6
Gene expression in mice with endothelium-specific telomerase knockout
Gao, Z., Yu, Y., Dai, Y., Zhao, Z., Eckel‐Mahan, K. L., & Kolonin, M. G. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1295072 · Cited by 5
Bocchetta, M., & Carbone, M. (2006) · Springer eBooks · doi:10.1007/0-387-28274-2_3 · Cited by 5
Lorigan, P. C., Medina, T. M., Nyakas, M., Rutten, A., Feun, L. G., Cowey, C. L., Payne, M., Hussain, I., Kuzel, T. M., O'Day, S. J., et al. (2025) · European Journal of Cancer · doi:10.1016/j.ejca.2025.116162 · Cited by 4
Dyskeratosis Congenita Links Telomere Attrition to Age-Related Systemic Energetics
James, E. N., Sági‐Kiss, V., Bennett, M. H., Mycielska, M. E., Karen‐Ng, L. P., Roberts, T., Matta, S., Dokal, I. S., Bundy, J. G., & Parkinson, E. K. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad018 · Cited by 5
“The TERT-HA construct was made by Meyerson and colleagues (37) and turned out to be very useful because it does not lengthen telomeres or immortalize cells (28) even when ectopically expressed making it a useful control for TERT overexpression and extrachromosomal (noncanonical) TERT functions (38).”
BackgroundDeciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer
Yeh, T., Luo, C., Du, J., Huang, C.-T., Wang, M.-H., Chuang, B. T.-M., Gau, Y., Cho, S., Liu, Y., Hsiao, H., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11030691 · Cited by 4
Telomerase and Cancer: A Promising Target
Falchetti, M. L., Pallini, R., & Levi, A. (2004) · American Journal of Cancer · doi:10.2165/00024669-200403010-00001 · Cited by 4
“[64-67] In a recent report,[68] it was been put forward to justify early activation of telomerase.”
BackgroundTelomeres and Telomerase in Humans
Hiyama, K., Hiyama, E., & Shay, J. W. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-879-9_1 · Cited by 4
Extracting Extra-Telomeric Phenotypes from Telomerase Mouse Models
Sung, Y. H., Ali, M., & Lee, H. (2013) · Yonsei Medical Journal · doi:10.3349/ymj.2014.55.1.1 · Cited by 5
Role of Telomeres and Telomerase in Cancer
Hiyama, K., Hiyama, E., Tanimoto, K., & Nishiyama, M. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-879-9_7 · Cited by 5
The Way to the End Matters: The Role of Telomerase in Tumor Progression
Bertuch, A. A., Buckley, K., & Lundblad, V. (2003) · Cell Cycle · doi:10.4161/cc.2.1.278 · Cited by 6
James, E. L., Teh, M., Li, Y., Wagner-Bock, C., Al-Khateeb, Z. F., Karen‐Ng, L. P., Roberts, T., Synchyshyn, L., Lewis, A. L., O’Loghlen, A., et al. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1583288 · Cited by 4
Bai, H., Bai, S., Li, X., Zhang, Y., Li, Y., He, F., & Cheng, W. (2021) · BioMed Research International · doi:10.1155/2021/3271395 · Cited by 3
“Indeed, immortalized cell lines can provide strong evidence in the cancer setting [32].”
BackgroundZantut‐Wittmann, D. E., Laus, A. C., Moreno, D. A., Barreto, I. S., Moma, C. A., Maia, F. F. R., Etchebehere, E. C. S. D. C., da Assumpção, L. V. M., & Reis, R. M. (2023) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2023.03.019 · Cited by 3
Yu, E. Y., & Hahn, W. C. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-8107-3_1 · Cited by 3
Self-citationTelomere Structural Dynamics in Genome Integrity Control and Carcinogenesis
Greenberg, R. A., & Rudolph, K. L. (2006) · Springer eBooks · doi:10.1007/1-4020-3764-3_11 · Cited by 3
Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro
Carbonare, L. D., Valenti, M. T., Bertoldo, F., Fracalossi, A., Balducci, E., Azzarello, G., Vinante, O., & Cascio, V. L. (2007) · Aging Clinical and Experimental Research · doi:10.1007/bf03324673 · Cited by 3
The molecular basis of cutaneous aging
Reddy, K. K., & Gilchrest, B. A. (2011) · Expert Review of Dermatology · doi:10.1586/edm.11.48 · Cited by 3
Nemirovich-Danchenko, N. M., & Khodanovich, M. Y. (2020) · Russian Journal of Genetics · doi:10.1134/s1022795420040092 · Cited by 3
“It must be emphasized that, according to numerous studies, the carcinogenic effect of telomerase does not depend on the elongation of telomeres [49, 116].”
BackgroundGiangaspero, F., Minasi, S., Gianno, F., Alzoubi, H., Antonelli, M., & Buttarelli, F. R. (2020) · Glioma · doi:10.4103/glioma.glioma_20_20 · Cited by 3
“Neoplastic cells from several tumor types (85%–90%) use the canonical TMM to maintain telomere length by reactivating telomerase expression, allowing them to escape from replicative senescence and apoptosis.[25,26] The main genetic alterations associated with telomerase-dependent TMM in tumor cells are (1) TERT promot…”
BackgroundTelomerase as a Potential Regulator of Tissue Progenitor Cells
Artandi, S. E. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_10 · Cited by 3
Zantut‐Wittmann, D. E., Barreto, I. S., Laus, A. C., Moreno, D. A., Moma, C. A., Maia, F. F. R., da Assumpção, L. V. M., & Reis, R. M. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.111931 · Cited by 2
Therapeutic targeting of telomerase ameliorates experimental choroidal neovascularization
Kumar, A., Nagasaka, Y., Jayananthan, V., Zidan, A. A., Heisler‐Taylor, T., Ambati, J., Tamiya, S., & Kerur, N. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167156 · Cited by 2
Telomerase Mutations and Premature Ageing in Humans
Du, H., Bessler, M., & Mason, P. J. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_5 · Cited by 2
Extra-Telomeric Effects of Telomerase (hTERT) in Cell Death
Bellot, G. L., & Wang, Y. (2013) · InTech eBooks · doi:10.5772/48583 · Cited by 2
“of TERT’s pro-tumorigenic function which is independent of its ability to maintain telomeres (Stewart et al., 2002).”
BackgroundInfluentialGreenwood, E. (2002) · Nature reviews. Cancer · doi:10.1038/nrc935 · Cited by 2
Cancer genetics: Finding the right mix
Boehm, J. S., & Hahn, W. C. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201477 · Cited by 2
Self-citationOf wombats and whales: telomere tales in Madrid
Karlseder, J., & Cooper, J. P. (2007) · EMBO Reports · doi:10.1038/sj.embor.7400985 · Cited by 3
Burke, K., Zhou, X., Wang, Y., & Wei, H. (2021) · OBM Geriatrics · doi:10.21926/obm.geriatr.2104184 · Cited by 1
“That ectopic expression of TERT could impart a tumorigenic phenotype to an immortal cell line without maintaining telomere length was further demonstrated by Steward, et al [30] in vitro and in vivo.”
BackgroundSV40 and Notch-I: Multi-functionality Meets Pleiotropy
Carbone, M., & Bocchetta, M. (2004) · Progress in molecular and subcellular biology · doi:10.1007/978-3-540-74264-7_14 · Cited by 1
“This hypothesis is supported by recent findings indicating that telomerase does participate in cell transformation, other than in immortalization of the cell (Stewart et al. 2002; Wong et al. 2002).”
ResultReview Article Tumorogensis: The Dual Role of Telomerase
Azhar, J. (2009) · Cited by 3
Mirzaee, R. (2014) · Journal of Molecular Biomarkers & Diagnosis · doi:10.4172/2155-9929.1000176 · Cited by 1
Telomerase as Biomarker in Colorectal Cancer
Bertorelle, R., & Rossi, A. D. (2015) · Biomarkers in disease · doi:10.1007/978-94-007-7681-4_2 · Cited by 1
Telomere and Telomerase in Cancer
Angayarkanni, J., Kiran, K. G., & PALANISWAMY, M. (2016) · InTech eBooks · doi:10.5772/64721 · Cited by 1
“Owing to its diverse activity, the telomerase [71] which was established to be absent in most of the normal human somatic cells is recorded to be expressed in more than 90% of cancerous cells and in vitro-immortalized cells [15, 70].”
BackgroundCell Culture Bioprocess Technology: Biologics and Beyond
O’Brien, S. A., Park, Y., Azarin, S. M., & Hu, W. (2018) · Learning materials in biosciences · doi:10.1007/978-3-319-74854-2_1 · Cited by 1
Zhu, S., Wang, J., Zhou, H., Zhao, Y., He, Y., Zellmer, L., Luo, Z., Wei, S., Deng, F., Huang, H., et al. (2020) · Cited by 1
Telomerase Level: A Useful Tool to Predict Longevity
Hertzog, R. G., Popescu, D., & Călborean, O. (2021) · Journal of Aging Science · doi:10.35248/2329-8847.21.9.251 · Cited by 1
“Through its role in maintaining the telomeres (irrespective of their length) [12], telomerase ensures the maintenance of the genetic (in) stability requested for continuing the cell division.”
BackgroundTelomerase as Biomarker in Colorectal Cancer
Bertorelle, R., & Rossi, A. D. (2014) · Springer eBooks · doi:10.1007/978-94-007-7744-6_2-1 · Cited by 1
Botchkina, I. L., Rivadeneira, D. E., Watkins, K. T., Karpeh, M. S., & Botchkina, G. I. (2008) · Molecular Medicine · doi:10.2119/2007-00069.botchkina · Cited by 1
Darbro, B. W. (2007) · doi:10.17077/etd.2qnj4kik · Cited by 1
“Furthermore, recent data suggests that TERT may have additional functions independent of the ability to maintain telomere length that may contribute to carcinogenesis (Chang & DePinho, 2002; Stewart et al., 2002).”
BackgroundYoshida, K., Yoshizato, A., Kakuo, S., Tahara, H., & Ide, T. (2004) · Tissue culture research communications : the journal of experimental & applied cell culture research · doi:10.11418/jtca1981.23.2_59 · Cited by 1
Telomerase Control by Epigenetic Processes in Cellular Senescence
Chen, H., & Tollefsbol, T. O. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0639-7_11 · Cited by 1
“TERT has been located to chromosome 5 at 5p15.33 (Bryce et al., 2000), TERC has been located to chromosome 3 at 3q26.3 ( Soder et al., 1997 ), and dyskerin has been located to Xq28.”
BackgroundRecent Molecular Studies of Marek's Disease Virus and Control Approaches for Increasing Virulence
Jang, H., Park, Y. M., Cha, S. Y., & Kwon, J. T. (2007) · Korean Journal of Poultry Science · doi:10.5536/kjps.2007.34.1.057 · Cited by 1
Papillomavirus infection and telomerase activation
Allen, H. K., & Klingelhutz, A. J. (2003) · Papillomavirus Report · doi:10.1179/095741903225001598 · Cited by 1
Hahn, W. C. (2003) · Cancer Research and Treatment · doi:10.4143/crt.2003.35.6.467 · Cited by 1
Self-citationTreatment-Induced Tumor Cell Senescence and Its Consequences
Broude, E. V. (2008) · CRC Press eBooks · doi:10.3109/9781420020502-15 · Cited by 1
Telomeres, Telomerase, Chromosome Stability, and Prostate Cancer
Meeker, A. K. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-224-3_18 · Cited by 1
Karenko, L. (2004) · Helda - University of Helsinki Institutional Repository
Control of gene expression in prostate epithelial cell differentiation hierarchy
Rane, J. K. (2012) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Bu, D.-X. (2006) · Figshare
Contributions of Telomerase to Tumorigenesis
Possemato, R., & Hahn, W. C. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-221-2_9 · Cited by 1
“For example, ALT phenotype cells harboring the SV40 ER and H-RAS fail to form tumors unless hTERT is co-expressed ( 75 ).”
BackgroundSelf-citationThe Embryonic Protein Nodal Supports Metastatic Phenotypes in Breast Cancer
Quail, D. F. (2012) · Scholarship@Western (Western University)
Telomerase: Key to Mortal or Immortal Road
Yang, E.-Y., Sung, Y. H., & Lee, H.-W. (2002) · Immune Network · doi:10.4110/in.2002.2.4.183
“Recently, it was reported that ALT could not substitute for telomerase expression and an additional function of hTERT that goes beyond its ability to elongate telomeres was required for cell transformation (53).”
BackgroundTRANSCRIPTOME STUDIES OF CELL-FATE AND AGING
Larsson, O. S. (2005) · Figshare
Telomerase and gene expression
Mooster, J. L. (2005)
Telomeres, Telomerase, and DNA Damage Response in Cancer Therapy
Tamakawa, R., Fleisig, H. B., & Wong, J. M. Y. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4741-2_11
“In contrast, the co-expression of TERT in these cells imparted a tumorigenic phenotype [ 176 ] .”
Background
Metadata
- Authors
- Stewart, S. A., Hahn, W. C., O'Connor, B. F., Banner, E. N., Lundberg, A. S., Modha, P., Mizuno, H., Brooks, M. W., Fleming, M., Zimonjic, D. B., Popescu, N. C., & Weinberg, R. A.
- Affiliations
- Brigham and Women's Hospital (US)
- Whitehead Institute for Biomedical Research, Cambridge, MA 02142; Department of Adult Oncology, Dana–Farber Cancer Institute, Boston, MA 02115; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115; Departments of Medicine and Pathology, Harvard Medical School, Boston, MA 02115; Genzyme, Inc., One Kendall Square, Cambridge, MA 02139; Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, MD 20892; and Department of Biology, Massachusetts Institute of...
- Corresponding author
- Weinberg, Robert A.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-08-22
- Volume
- 99
- Issue
- 20
- Pages
- 12606-12611
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC130507
- OpenAlex
- W2154837214
- Cited by
- 431
- References
- 53
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 6 · 2023: 7 · 2022: 6 · 2021: 9 · 2020: 9 · 2019: 11 · 2018: 5 · 2017: 14 · 2016: 21 · 2015: 18 · 2014: 22 · 2013: 15 · 2012: 18
- FWCI
- 23.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- American Association for Cancer Research
- W. M. Keck Foundation
- Ludwig Institute for Cancer Research
- National Institutes of Health
- National Cancer Institute (KO1CA94223, R01 CA78461, K01CA094223, R01CA078461)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- telomerase, hTERT, alternative lengthening of telomeres, carcinogenesis, cell transformation, cell immortalization, replicative lifespan
- MeSH terms
- Catalysis, Cell Division, Cell Transformation, Neoplastic, DNA-Binding Proteins, Electrophoresis, Polyacrylamide Gel, Glucose, Humans, Karyotyping, Kinetics, Luminescent Proteins, Microscopy, Fluorescence, Oxygen, Retroviridae, Time Factors, Tumor Cells, Cultured, Blotting, Western, Telomere, Telomerase, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.